NCT05017350

Hemostasis Using Radiofrequency Ablation for Track Bleeding

Hemostasis Using Radiofrequency Ablation for Track Bleeding After Liver Biopsy

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 10 (estimated)
• Sponsor: Kyoung Doo Song · Academic / Other
• Sex: All
• Age: 20 Years – 79 Years
• Healthy volunteers: Not accepted

Summary

This study aims to evaluate the usefulness of hemostasis using radiofrequency ablation for track bleeding that has occurred after percutaneous biopsy of the liver.

Detailed description

Purpose: To evaluate the usefulness of hemostasis using radiofrequency ablation for track bleeding after percutaneous liver biopsy. Method: * Enroll patients who continue to bleed despite conservative treatment for track bleeding that has occurred after liver biopsy. * Radiofreqeuncy ablation: Under monitoring vital signs and controlling pain with intravenous agents, the electrode is inserted into the bleeding focus. The bleeding focus is ablated. * Hemostasis is evaluated by ultrasound (right after radiofrequency ablation), CT scan (after the radiofrequency ablation), and ultrasound (the day after radiofrequency ablation) * If hemostasis fails using radiofrequency ablation, transarterial hepatic embolization is performed immediately.

Conditions

• Bleeding

Interventions

Type	Name	Description
PROCEDURE	radiofrequency ablation	Under the ultrasound guidance, the electrode is inserted into the bleeding focus of the liver and the bleeding focus is ablated.

Timeline

• Start date: 2021-07-01
• Primary completion: 2024-12-31
• Completion: 2024-12-31
• First posted: 2021-08-23
• Last updated: 2021-08-23

Locations

1 site across 1 country: South Korea